APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Outlook and Growth Opportunities 2026

20 December 2025199 pages

Choose your research edition.

Industry ResearchDipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market include Boehringer, Bristol-Myers Squibb, AstraZeneca, Glaxo Smith Kline, Pfizer, Eli Lilly, Novo Nordisk and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dipeptidyl Peptidase-4 (DPP-4) Inhibitors sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market size, projected growth trends, production technologies, key applications, and end-use industries.

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Company

Boehringer

Bristol-Myers Squibb

AstraZeneca

Glaxo Smith Kline

Pfizer

Eli Lilly

Novo Nordisk

Sanofi

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Type

Sitagliptin

Vildagliptin

Saxagliptin

Linagliptin

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Application

Hospital

Clinic

Others

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dipeptidyl Peptidase-4 (DPP-4) Inhibitors significant trends, drivers, influence factors in global and regions.

6. To analyze Dipeptidyl Peptidase-4 (DPP-4) Inhibitors competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors industry.

Chapter 3: Detailed analysis of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Trends Table 2. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Drivers Table 3. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Opportunities and Challenges Table 4. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Restraints Table 5. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Company (2021-2026) Table 7. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume Share by Company (2021-2026) Table 9. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Company Ranking, (2024-2026) & (USD Million) Table 11. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Key Company Manufacturing Base & Headquarters Table 12. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Company, Product Type & Application Table 13. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Sitagliptin Table 18. Significant Companies of Vildagliptin Table 19. Significant Companies of Saxagliptin Table 20. Significant Companies of Linagliptin Table 21. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume Share by Type (2021-2026) Table 25. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume Share by Type (2027-2032) Table 26. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type (2021-2026) Table 30. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of Clinic Table 33. Significant Companies of Others Table 34. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume Share by Application (2021-2026) Table 38. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume Share by Application (2027-2032) Table 39. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application (2021-2026) Table 43. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application (2027-2032) Table 44. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2021-2026) & (K Units) Table 46. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2021-2026) Table 47. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2027-2032) & (K Units) Table 48. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2027-2032) Table 49. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Region (2021-2026) Table 52. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Region (2027-2032) Table 54. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021-2026) & (K Units) Table 59. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2021-2026) Table 60. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2027-2032) & (K Units) Table 61. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2027-2032) Table 62. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Market Share by Country (2021-2026) Table 64. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Market Share by Country (2027-2032) Table 66. Boehringer Company Information Table 67. Boehringer Business Overview Table 68. Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 70. Boehringer Recent Development Table 71. Bristol-Myers Squibb Company Information Table 72. Bristol-Myers Squibb Business Overview Table 73. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 75. Bristol-Myers Squibb Recent Development Table 76. AstraZeneca Company Information Table 77. AstraZeneca Business Overview Table 78. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 80. AstraZeneca Recent Development Table 81. Glaxo Smith Kline Company Information Table 82. Glaxo Smith Kline Business Overview Table 83. Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 85. Glaxo Smith Kline Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 90. Pfizer Recent Development Table 91. Eli Lilly Company Information Table 92. Eli Lilly Business Overview Table 93. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 95. Eli Lilly Recent Development Table 96. Novo Nordisk Company Information Table 97. Novo Nordisk Business Overview Table 98. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 100. Novo Nordisk Recent Development Table 101. Sanofi Company Information Table 102. Sanofi Business Overview Table 103. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 105. Sanofi Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Distributors List Table 109. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Image Figure 2. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value (2021-2032) & (US$ Million) Figure 4. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (2021-2032) & (K Units) Figure 5. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Sitagliptin Image Figure 10. Vildagliptin Image Figure 11. Saxagliptin Image Figure 12. Linagliptin Image Figure 13. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume Share by Type (2021-2032) Figure 16. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Others Image Figure 22. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume Share by Application (2021-2032) Figure 25. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application (2021-2032) Figure 28. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value (2021-2032) & (US$ Million) Figure 33. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value (2021-2032) & (US$ Million) Figure 39. South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Sitagliptin
  • Vildagliptin
  • Saxagliptin
  • Linagliptin
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Boehringer
  • Bristol-Myers Squibb
  • AstraZeneca
  • Glaxo Smith Kline
  • Pfizer
  • Eli Lilly
  • Novo Nordisk
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value (2021-2032)
  4. 1.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume (2021-2032)
  5. 1.2.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Dynamics
  1. 2.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Trends
  2. 2.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Drivers
  3. 2.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Opportunities and Challenges
  4. 2.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Restraints
3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market by Company
  1. 3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Company Revenue Ranking in 2025
  2. 3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Company (2021-2026)
  3. 3.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume by Company (2021-2026)
  4. 3.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Average Price by Company (2021-2026)
  5. 3.5 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Company Ranking (2024-2026)
  6. 3.6 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Company Manufacturing Base and Headquarters
  7. 3.7 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Company Product Type and Application
  8. 3.8 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market by Type
  1. 4.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Type Introduction
  2. 4.1.1 Sitagliptin
  3. 4.1.2 Vildagliptin
  4. 4.1.3 Saxagliptin
  5. 4.1.4 Linagliptin
  6. 4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume by Type
  7. 4.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Type
  11. 4.3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Type (2021-2032)
  13. 4.3.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type (2021-2032)
5 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market by Application
  1. 5.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume by Application
  6. 5.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Application
  10. 5.3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Application (2021-2032)
  12. 5.3.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application (2021-2032)
6 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Regional Sales and Value Analysis
  1. 6.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2021-2032)
  3. 6.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region: 2021-2026
  4. 6.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2027-2032)
  5. 6.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Region (2021-2032)
  7. 6.4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Region: 2021-2026
  8. 6.4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Region (2027-2032)
  9. 6.5 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value (2021-2032)
  12. 6.6.2 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value (2021-2032)
  15. 6.7.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value (2021-2032)
  21. 6.9.2 South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Country, 2025 VS 2032
7 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Country-level Sales and Value Analysis
  1. 7.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021-2032)
  4. 7.3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021-2026)
  5. 7.3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2027-2032)
  6. 7.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Country (2021-2032)
  7. 7.4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Country (2021-2026)
  8. 7.4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer
  2. 8.1.1 Boehringer Company Information
  3. 8.1.2 Boehringer Business Overview
  4. 8.1.3 Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  6. 8.1.5 Boehringer Recent Developments
  7. 8.2 Bristol-Myers Squibb
  8. 8.2.1 Bristol-Myers Squibb Company Information
  9. 8.2.2 Bristol-Myers Squibb Business Overview
  10. 8.2.3 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  12. 8.2.5 Bristol-Myers Squibb Recent Developments
  13. 8.3 AstraZeneca
  14. 8.3.1 AstraZeneca Company Information
  15. 8.3.2 AstraZeneca Business Overview
  16. 8.3.3 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  18. 8.3.5 AstraZeneca Recent Developments
  19. 8.4 Glaxo Smith Kline
  20. 8.4.1 Glaxo Smith Kline Company Information
  21. 8.4.2 Glaxo Smith Kline Business Overview
  22. 8.4.3 Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  24. 8.4.5 Glaxo Smith Kline Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Eli Lilly
  32. 8.6.1 Eli Lilly Company Information
  33. 8.6.2 Eli Lilly Business Overview
  34. 8.6.3 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  36. 8.6.5 Eli Lilly Recent Developments
  37. 8.7 Novo Nordisk
  38. 8.7.1 Novo Nordisk Company Information
  39. 8.7.2 Novo Nordisk Business Overview
  40. 8.7.3 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  42. 8.7.5 Novo Nordisk Recent Developments
  43. 8.8 Sanofi
  44. 8.8.1 Sanofi Company Information
  45. 8.8.2 Sanofi Business Overview
  46. 8.8.3 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  48. 8.8.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Value Chain Analysis
  2. 9.1.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Mode & Process
  6. 9.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Distributors
  9. 9.2.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst